FDA authorized Tec-Dara for RRMM after ≥1 prior line (PI + IMiD exposure), accelerating earlier-line use where attrition and refractoriness erode response with successive regimens. A 55-day review ...

Rallybio Corporation (Nasdaq: RLYB) ("Rallybio") and Candid Therapeutics, Inc. ("Candid"), a global clinical-stage biotechnology company advancing a leading portfolio of T-cell engager ("TCE") ...

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into ...

Healthcare professionals should tailor transfusion support by finding rare donors or using immunosuppressants to help decrease rates of alloimmune platelet transfusion refractoriness. Precision ...

APART from experiments reported in 1954 by Barnes and Duff 1, the occurrence of tachyphylaxis to poisons which act by inhibiting cholinesterase has been little publicized, although the phenomenon ...

The aim of this review was to assess whether specially treated pathogen-reduced platelets, work as well as normal platelets when transfused. Specifically, do they stop or prevent bleeding as well as ...

Abstract: In this research, we propose a Self-Organizing Map with Refractoriness (SOMR) and apply it to a similarity-based image retrieval. The proposed SOMR is based on the Self-Organizing Map (SOM) ...

The proportion of responders was 39.1% among patients with single-class refractory disease and 33.7% among patients with penta-class refractory disease. Patients with relapsed or refractory multiple ...

This study included 844 patients with Barcelona Clinic Liver Cancer (BCLC) stage B HCC from a multicenter dataset. Propensity score matching (PSM) was used to minimize baseline differences between the ...

Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...